Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP
14 mai 2020 09h33 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Premas...
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
08 avr. 2020 09h25 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its...
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
24 mars 2020 09h00 HE
|
Akers Biosciences Inc.
Established D-Crypt™ platform will be used to develop a proof-of-concept targeting three of the top five viral vaccine protein candidates for CoronavirusCurrent Regulatory environment could lead to...